In cancer cells, thiosemicarbazones, particularly those presenting a thio carbonyl (C=S) bond, have been shown to interfere specifically with the function of RLP44 during the elongation step of translation by inhibiting the crosslinking reaction between RPL44 and the periodate-oxidized tRNA [32]. The gene discussed is RPL36A; the disease is cancer.